HONG KONG -- China's COVID-testing companies face stiff headwinds after Beijing's abrupt U-turn on its virus policies, with many likely to suffer from shrinking business following the end of mass compulsory testing.
Mass compulsory testing was huge boom for suppliers of high-margin PCR kits

A man takes a PCR test in Beijing on Dec. 16. The government's abrupt U-turn on its virus policies will mean shrinking business for many test kit suppliers. © Kyodo
HONG KONG -- China's COVID-testing companies face stiff headwinds after Beijing's abrupt U-turn on its virus policies, with many likely to suffer from shrinking business following the end of mass compulsory testing.